VEGFA and renal cell carcinoma: Furthermore, we observed that patients treated with VEGF-TT in between the resection of their primary RCC and subsequent metastasis had numerically higher c-Met expression in metastatic sites compared to those who did not receive systemic therapy before the resection of the metastases.